Comparison

RIPK-IN-4 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 10 mg
Item no. HY-107978-10mg
CASRN 2141969-56-2
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
RIPK-IN-4 is a potent and selective RIPK2 inhibitor with excellent oral bioavailability, and has an IC50 of 3 nM[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
392.45
Clinical_Information
No Development Reported
Manufacturers Research_Area
Inflammation/Immunology
Solubility
DMSO : 31.25 mg/mL (ultrasonic)
Manufacturers Target
RIP kinase
Isoform
RIPK2
Pathway
Apoptosis
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close